Anti-estrogenic therapies + immune checkpoint inhibitor therapies = potential cancer treatment
Key Points:
- Anti-estrogenic therapies have shown the ability to suppress the growth of estrogen receptor-negative cancer.
- In mice models, combining anti-estrogenic therapies with immune checkpoint inhibitor therapies has led to a halt in tumor progression.
- This combination approach holds promise for potential future cancer treatment.
Hot take:
Who would have thought that combining anti-estrogenic therapies with immune checkpoint inhibitor therapies could be a knockout combo against cancer? These sneaky mice models have shown us the potential of this treatment approach, giving hope for the future of cancer treatment. It seems like the cancer cells are going to have a hard time putting up a fight with this dynamic duo!
Original article: https://www.sciencedaily.com/releases/2023/08/230821114358.htm